Biotech Unusual Volume: Reliv International (NASDAQ:RELV), Transcept Pharmaceuticals (NASDAQ:TSPT), Aastrom Biosciences (NASDAQ:ASTM), Bacterin International Holdings (NYSEMKT:BONE)

Reliv International, Inc. (NASDAQ:RELV) a maker of nutritional supplements that promote optimal health, on March 5 reported its financial results for the fourth quarter and full year of 2013. Reliv International, Inc. (NASDAQ:RELV) stock performance was 2.05% in last session and finished the day at $2.02. Traded volume was 38,868.00 shares in the last session and the average volume of the stock remained 11,999.00 shares. … Continue reading Biotech Unusual Volume: Reliv International (NASDAQ:RELV), Transcept Pharmaceuticals (NASDAQ:TSPT), Aastrom Biosciences (NASDAQ:ASTM), Bacterin International Holdings (NYSEMKT:BONE)

Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

An increase in European and U.S. sales helped Reliv International Inc. (NASDAQ:RELV) raise profits by a small amount in the fourth quarter. Reliv International, Inc (NASDAQ:RELV) stock performance was -11.60% in last session and finished the day at $2.03. Traded volume was 64,448.00million shares in the last session and the average volume of the stock remained 10.29K shares. The beta of the stock remained 1.35. … Continue reading Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

Healthcare Bullish Stocks: Reliv International (NASDAQ:RELV), Flexion Therapeutics (NASDAQ:FLXN), Relypsa Inc (NASDAQ:RLYP), Sucampo Pharmaceuticals (NASDAQ:SCMP)

Reliv International, Inc (NASDAQ:RELV) reported net sales of $14.5 million for the first quarter of 2014, compared to net sales of $18.9 million for the first quarter of 2013. Net sales in the United States declined by 29.2 percent for the quarter compared to the same quarter in 2013. Reliv International, Inc (NASDAQ:RELV) stock performance was 7.37% in last session and finished the day at … Continue reading Healthcare Bullish Stocks: Reliv International (NASDAQ:RELV), Flexion Therapeutics (NASDAQ:FLXN), Relypsa Inc (NASDAQ:RLYP), Sucampo Pharmaceuticals (NASDAQ:SCMP)

Biotech Bullish Stocks: Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), Reliv International, Inc (NASDAQ:RELV), Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX)

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has seen a massive down tick in the past few trading sessions, and analysts believe that this downward trajectory might continue for the stock and may lead it to lower levels. Short term traders can short the stock at current levels with a tight stop loss at $11 for targets of $8 or lower. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was … Continue reading Biotech Bullish Stocks: Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), Reliv International, Inc (NASDAQ:RELV), Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX)

Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera Therapeutics (NASDAQ:OCRX), MediciNova (NASDAQ:MNOV), PTC Therapeutics (NASDAQ:PTCT)

Registrant and three of its wholly-owned subsidiaries, Reliv, International, Inc (NASDAQ:RELV), Reliv World Corporation and SL Technology, Inc. entered into a Credit Agreement with BMO Harris Bank N.A. (the “Bank”) pursuant to which the Bank agreed to provide certain credit facilities to Registrant, including a Term Loan in the principal amount of $3,481,961 and a revolving credit facility in the amount of $5,000,000. Reliv International, … Continue reading Biotech Bearish Stocks: Reliv International (NASDAQ:RELV), Ocera Therapeutics (NASDAQ:OCRX), MediciNova (NASDAQ:MNOV), PTC Therapeutics (NASDAQ:PTCT)

FB Nasdaq FB Facebook

Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) major shareholder Sabby Management, Llc acquired 16,203 shares of Celsus Therapeutics PLC stock in a transaction dated Thursday, March 27th. The shares were purchased at an average price of $6.66 per share, for a total transaction of $107,911.98. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock performance was -5.24% in last session and finished the day at $6.15. Traded volume was 35.9K … Continue reading Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)